Georgetown University-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Georgetown University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013595
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Georgetown University (GU) is an academic and research institution which offers educational services. It provides undergraduate and graduate degree programs in the fields of law, medical, medical residencies, business administration and public policy degrees, post-doctoral positions, specialized certificates and continuing education programs. GU offers educational services in the areas of business and economics and comparative literature, history, international affairs, language and linguistics, liberal and professional studies, sciences, social sciences, mathematics and computer science, and visual and performing arts and film studies, among others. The university also offers research services through its scientific centers and institutes. GU is headquartered in Washington, Washington D.C., the US.

Georgetown University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Georgetown University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Georgetown University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Georgetown University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Georgetown University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Georgetown University, Medical Devices Deals, 2011 to YTD 2017 9
Georgetown University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Georgetown University, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Georgetown Lombardi Comprehensive Cancer Center Partners with John Theurer Cancer Center 11
CalAsia Pharma Enters Into Co-Development Agreement With Georgetown University 12
Licensing Agreements 13
Amarantus BioScience Enters into Option for Licensing Agreement with Georgetown University 13
BioMetrx Enters Into Licensing Agreement With Georgetown University Medical Center For Rasstore 14
Ariadne Genomics Enters Into Licensing Agreement With Georgetown University 15
Georgetown University – Key Competitors 16
Georgetown University – Key Employees 17
Georgetown University – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 22
Government and Public Interest 22
Jun 30, 2016: CANTAB Research Grant 2016 – Results 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Georgetown University, Pharmaceuticals & Healthcare, Key Facts 2
Georgetown University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Georgetown University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Georgetown University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Georgetown University, Deals By Therapy Area, 2011 to YTD 2017 8
Georgetown University, Medical Devices Deals, 2011 to YTD 2017 9
Georgetown University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Georgetown Lombardi Comprehensive Cancer Center Partners with John Theurer Cancer Center 11
CalAsia Pharma Enters Into Co-Development Agreement With Georgetown University 12
Amarantus BioScience Enters into Option for Licensing Agreement with Georgetown University 13
BioMetrx Enters Into Licensing Agreement With Georgetown University Medical Center For Rasstore 14
Ariadne Genomics Enters Into Licensing Agreement With Georgetown University 15
Georgetown University, Key Competitors 16
Georgetown University, Key Employees 17
Georgetown University, Key Employees (cont..) 19
Georgetown University, Other Locations 20
Georgetown University, Subsidiaries 20

★海外企業調査レポート[Georgetown University-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • QVC Inc:企業の戦略的SWOT分析
    QVC Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Wolfgang Puck Worldwide Inc:企業の戦略・SWOT・財務分析
    Wolfgang Puck Worldwide Inc - Strategy, SWOT and Corporate Finance Report Summary Wolfgang Puck Worldwide Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • The Tokyo Star Bank Ltd:企業の戦略・SWOT・財務情報
    The Tokyo Star Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The Tokyo Star Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Fraser & Neave Holdings Bhd:戦略・SWOT・企業財務分析
    Fraser & Neave Holdings Bhd - Strategy, SWOT and Corporate Finance Report Summary Fraser & Neave Holdings Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • SR One Ltd-製薬・医療分野:企業M&A・提携分析
    Summary SR One Ltd (SR One), a subsidiary of GlaxoSmithKline Plc is a venture capital firm that offers investment services for seed, start up, early and mid venture; and emerging growth companies. The firm invests globally in emerging life science companies that are pursuing innovative science which …
  • Formula Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Formula Pharmaceuticals Inc (Formula Pharmaceuticals) is a biopharmaceutical company that develops chimeric antigen receptor immunotherapy for oncology and autoimmune diseases. The company provides its pipeline products such as CIK-CAR.CD19, used as B-lymphocyte surface antigen; CIK-CAR.CD33 …
  • Stena AB:企業の戦略的SWOT分析
    Stena AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Thin Film Electronics ASA (THIN):企業の財務・戦略的SWOT分析
    Thin Film Electronics ASA (THIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Port of Rotterdam Authority NV:企業の戦略的SWOT分析
    Port of Rotterdam Authority NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Allergy Therapeutics Plc (AGY):企業の財務・戦略的SWOT分析
    Allergy Therapeutics Plc (AGY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Proengin SA:企業の戦略・SWOT・財務分析
    Proengin SA - Strategy, SWOT and Corporate Finance Report Summary Proengin SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Armstrong World Industries, Inc:企業の戦略・SWOT・財務情報
    Armstrong World Industries, Inc - Strategy, SWOT and Corporate Finance Report Summary Armstrong World Industries, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Yoho Resources Inc. (YO)-石油・ガス分野:企業M&A・提携分析
    Summary Yoho Resources Inc. (Yoho) is an upstream oil and gas exploration company. The company carries out exploration, development and production of crude oil and natural gas liquid, and natural gas. The company has operations within the Western Canadian Sedimentary Basin focusing exploration activ …
  • Seattle Genetics Inc (SGEN)-製薬・医療分野:企業M&A・提携分析
    Summary Seattle Genetics Inc (Seattle Genetics) is a biotechnology company that develops and commercializes monoclonal antibody-based therapies for the treatment of cancer. The company's lead product Adcetris (brentuximab vedotin) is an antibody-drug conjugate indicated for the treatment of relapsed …
  • Hurricane Energy Plc (HUR):石油・ガス:M&Aディール及び事業提携情報
    Summary Hurricane Energy Plc (Hurricane) is an oil and gas exploration and development company that discovers and develops oil from fractured basement reservoirs. The company provides exploration properties such as lancaster basement prospect, whirlwind basement discovery, lincoln basement prospect, …
  • Hamilton Thorne Ltd (HTL):企業の財務・戦略的SWOT分析
    Summary Hamilton Thorne Ltd (Hamilton Thorne) is a medical equipment company that offers precision laser devices and advanced image analysis systems. The company's products include clinical lasers, animal and research sperm analysis products, research lasers, clinical sperm analysis products, sperm …
  • Welbilt, Inc. (WBT):企業の財務・戦略的SWOT分析
    Welbilt, Inc. (WBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Scorpio Tankers Inc (STNG):石油・ガス:M&Aディール及び事業提携情報
    Summary Scorpio Tankers Inc. (Scorpio Tankers), a part of Scorpio Group, provides marine transportation of refined petroleum products and crude oil worldwide. The company operates through a network of owned and time chartered vessels, which distribute vegetable oils, petroleum-based feedstock and re …
  • NorthWestern Corp:企業の発電所・SWOT分析2018
    NorthWestern Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Maersk Tankers AS:石油・ガス:M&Aディール及び事業提携情報
    Summary Maersk Tankers AS (Maersk Tankers), a subsidiary of A.P. Moeller Holding AS is an oil and gas company that offers energy transportation services through oil tankers. The company provides services such as crude oil and refined oil transportation, warehousing and distribution, supply chain man …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆